The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Clinical outcomes and correlation with longitudinal circulating tumor (ct)DNA dynamics of a phase I/II study of GSK525762 combined with fulvestrant in patients with hormone receptor-positive/HER2-negative (HR+/HER2−) advanced or metastatic breast cancer.
 
David W. Cescon
Consulting or Advisory Role - AstraZeneca; Eisai; Gilead Sciences; GlaxoSmithKline; INFLEX; Lilly; Merck; Novartis; Pfizer; SAGA Diagnostics
Research Funding - AstraZeneca (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Inivata (Inst); Knight Therapeutics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Patent (US62/675,228) for methods of treating cancers characterized by a high expression level of spindle and kinetochore associated complex subunit 3 (ska3) gene.
Expert Testimony - AstraZeneca
(OPTIONAL) Uncompensated Relationships - Inivata
 
John Frederick Hilton
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Lilly O.; Merck; Novartis; Pfizer; Seagen
Research Funding - DMSC; GlaxoSmithKline
Other Relationship - Bristol-Myers Squibb
 
Kirsty Hicks
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Qu Zhang
Employment - Bristol-Myers Squibb; GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
Patents, Royalties, Other Intellectual Property - As a co-inventor for a pending patent
 
Olena Barbash
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Arindam Dhar
Employment - GlaxoSmithKline
Stock and Other Ownership Interests - GlaxoSmithKline
 
Mafalda Oliveira
Honoraria - Eisai Europe; Gilead Sciences; MSD; Novartis; Pfizer; Roche; SeaGen
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Gilead Sciences; ITeos Therapeutics; Relay Therapeutics; Roche/Genentech; Seagen
Research Funding - AstraZeneca (Inst); Ayala Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Roche/Genentech (Inst); Seagen (Inst); Zenith Epigenetics (Inst)
Travel, Accommodations, Expenses - AstraZeneca Spain; Eisai; Gilead Sciences; Pierre Fabre
 
Joseph A. Sparano
Consulting or Advisory Role - AstraZeneca; BMSi; Eisai; Exact Sciences; Genentech/Roche; General Dynamics Information Technology (GDIT); General Electric; GlaxoSmithKline; Lilly; Lyell Immunopharma; Novartis; NSABP Foundation; Pfizer; Sanofi/Aventis; Seagen; Seagen
Research Funding - Deciphera (Inst); Olema Pharmaceuticals (Inst); Radius Health (Inst)